tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Corcept Therapeutics’ Earnings Call Highlights Growth Amid Challenges
Company AnnouncementsCorcept Therapeutics’ Earnings Call Highlights Growth Amid Challenges
7h ago
CORT
Corcept Therapeutics Reports Q3 Growth and Expands Oncology Programs
PremiumCompany Announcements
Corcept Therapeutics Reports Q3 Growth and Expands Oncology Programs
1d ago
CORT
Corcept Therapeutics reports Q3 EPS 16c, consensus 14c
PremiumThe Fly
Corcept Therapeutics reports Q3 EPS 16c, consensus 14c
1d ago
CORT
Corcept Therapeutics Reports Q3 2025 Revenue Growth
PremiumCompany Announcements
Corcept Therapeutics Reports Q3 2025 Revenue Growth
1d ago
8K
CORT
CORT Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
CORT Upcoming Earnings Report: What to Expect?
10d ago
CORT
Promising Potential of Corcept Therapeutics’ Relacorilant in Ovarian Cancer Treatment Drives Buy Rating
PremiumRatingsPromising Potential of Corcept Therapeutics’ Relacorilant in Ovarian Cancer Treatment Drives Buy Rating
17d ago
CORT
Corcept submits relacorilant marketing authorization application to EMA
Premium
The Fly
Corcept submits relacorilant marketing authorization application to EMA
23d ago
CORT
Corcept Therapeutics Ends Distribution Agreement with Optime
Premium
Company Announcements
Corcept Therapeutics Ends Distribution Agreement with Optime
23d ago
8K
CORT
Corcept Therapeutics falls -13.3%
PremiumThe Fly
Corcept Therapeutics falls -13.3%
27d ago
CORT
H.C. Wainwright says buy Corcept on weakness after Optime exit
PremiumThe Fly
H.C. Wainwright says buy Corcept on weakness after Optime exit
27d ago
CORT
Corcept lower after Optime Care terminates distributor agreement for Korlym
PremiumThe Fly
Corcept lower after Optime Care terminates distributor agreement for Korlym
27d ago
CORT
Corcept Therapeutics falls -15.0%
PremiumThe Fly
Corcept Therapeutics falls -15.0%
27d ago
CORT
Corcept Therapeutics Board Member Resigns, Continues as Consultant
PremiumCompany AnnouncementsCorcept Therapeutics Board Member Resigns, Continues as Consultant
1M ago
8K
CORT
Corcept Therapeutics management to meet with Truist
Premium
The Fly
Corcept Therapeutics management to meet with Truist
1M ago
CORT
Corcept Therapeutics price target raised to $140 from $137 at Canaccord
Premium
The Fly
Corcept Therapeutics price target raised to $140 from $137 at Canaccord
2M ago
CORT
Corcept Therapeutics’ New Drug Application Accepted by FDA
PremiumCompany Announcements
Corcept Therapeutics’ New Drug Application Accepted by FDA
2M ago
8K
CORT
Corcept Therapeutics announces FDA acceptance of relacorilant NDA
PremiumThe Fly
Corcept Therapeutics announces FDA acceptance of relacorilant NDA
2M ago
CORT
Corcept Therapeutics: Buy Rating Backed by Promising Developments in Glucocorticoid Modulation and Oncology Expansion
PremiumRatings
Corcept Therapeutics: Buy Rating Backed by Promising Developments in Glucocorticoid Modulation and Oncology Expansion
3M ago
CORT
Corcept Therapeutics’ Earnings Call: Growth Amid Challenges
PremiumCompany Announcements
Corcept Therapeutics’ Earnings Call: Growth Amid Challenges
3M ago
CORT
Corcept Therapeutics price target lowered to $121 from $131 at Piper Sandler
PremiumThe FlyCorcept Therapeutics price target lowered to $121 from $131 at Piper Sandler
3M ago
CORT
Corcept Therapeutics price target lowered to $137 from $142 at Canaccord
Premium
The Fly
Corcept Therapeutics price target lowered to $137 from $142 at Canaccord
3M ago
CORT
Corcept Therapeutics: Buy Rating Backed by Strategic Growth Initiatives and Promising Product Launches
Premium
Ratings
Corcept Therapeutics: Buy Rating Backed by Strategic Growth Initiatives and Promising Product Launches
3M ago
CORT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >